{"DataElement":{"publicId":"2431556","version":"1","preferredName":"Nottingham Histopathologic Grade Total Score Integer","preferredDefinition":"An aggregate score indicating the histopathologic grade of an invasive breast carcinoma, determined by summing the scores for Mitotic Count, Pleomorphism and Tubule Formation.","longName":"2431350v1.0:2432058v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2431350","version":"1","preferredName":"Nottingham Score Total Nottingham Score","preferredDefinition":"A numeric representation combining three histologic reporting elements, tubulin formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer. The Nottingham Score is a factor in determining the Nottingham Prognostic Index._definition pending","longName":"2431279v1.0:2431223v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2431279","version":"1","preferredName":"Nottingham Score","preferredDefinition":"A numeric representation combining three histologic reporting elements, tubulin formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer. The Nottingham Score is a factor in determining the Nottingham Prognostic Index.","longName":"C25595","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nottingham Score","conceptCode":"C25595","definition":"A numeric representation combining three histologic reporting elements, tubule formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer. The Nottingham Score is a factor in determining the Nottingham Prognostic Index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF1C9-10BC-3A91-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2431223","version":"1","preferredName":"Total Nottingham Score","preferredDefinition":"definition pending","longName":"C48934","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total Nottingham Score","conceptCode":"C48934","definition":"A scoring system used to determine the grade of invasive breast carcinoma.  The total score is determined by the summation of three values (scores), each numbered 1-3.  The three values correspond to the degree of tubular formation, the degree of nuclear pleomorphism, and the mitotic counts per 10 high power fields, respectively.  The sum of the three values produces a total score of 3-9.  Lesions with total score 3-5, are grade I; lesions with total score 6-7, are grade 2.  Lesions with total score 8-9, are grade 3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCE34D-B16B-3334-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE0152-8207-40C5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2432058","version":"1","preferredName":"Total Nottingham Score Integer","preferredDefinition":"A score ranging from 1-9 representing the sum of the scores for tubule formation, nuclear pleomorphism and mitotic count._A number with no fractional part._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"2432058v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":"1","maxLength":"1","minValue":"3","maxValue":"9","decimalPlace":null,"PermissibleValues":[{"value":"3","valueDescription":"Grade I","ValueMeaning":{"publicId":"2568891","version":"1","preferredName":"Grade I","longName":"2568891","preferredDefinition":"Grade I","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA28-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"062E16DD-541D-16F1-E044-0003BA3F9857","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","deletedIndicator":"No"},{"value":"4","valueDescription":"Grade I","ValueMeaning":{"publicId":"2568891","version":"1","preferredName":"Grade I","longName":"2568891","preferredDefinition":"Grade I","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA28-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"062E16DD-541F-16F1-E044-0003BA3F9857","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","deletedIndicator":"No"},{"value":"5","valueDescription":"Grade I","ValueMeaning":{"publicId":"2568891","version":"1","preferredName":"Grade I","longName":"2568891","preferredDefinition":"Grade I","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA28-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"062E16DD-5420-16F1-E044-0003BA3F9857","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","deletedIndicator":"No"},{"value":"6","valueDescription":"Grade II","ValueMeaning":{"publicId":"2568892","version":"1","preferredName":"Grade II","longName":"2568892","preferredDefinition":"Grade II","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA29-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"062E16DD-5421-16F1-E044-0003BA3F9857","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","deletedIndicator":"No"},{"value":"7","valueDescription":"Grade II","ValueMeaning":{"publicId":"2568892","version":"1","preferredName":"Grade II","longName":"2568892","preferredDefinition":"Grade II","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA29-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"062E16DD-5422-16F1-E044-0003BA3F9857","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","deletedIndicator":"No"},{"value":"8","valueDescription":"Grade III","ValueMeaning":{"publicId":"2568893","version":"1","preferredName":"Grade III","longName":"2568893","preferredDefinition":"Grade III","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA2A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"062E16DD-5423-16F1-E044-0003BA3F9857","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","deletedIndicator":"No"},{"value":"9","valueDescription":"Grade III","ValueMeaning":{"publicId":"2568893","version":"1","preferredName":"Grade III","longName":"2568893","preferredDefinition":"Grade III","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA2A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"062E16DD-5424-16F1-E044-0003BA3F9857","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2183782","version":"1","preferredName":"NCIP","preferredDefinition":"Cancer Biomedical Informatics Grid","longName":"NCIP","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DACB2549-3BE3-73F7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2434851","version":"1","preferredName":"Score Integer","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.:A number with no fractional part.","longName":"C25338:C45255","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0643AECC-B7FB-298D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-30","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-30","modifiedBy":"ONEDATA","dateModified":"2005-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"061284D5-18ED-0705-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-21","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-21","modifiedBy":"CURTIST","dateModified":"2010-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2534075","version":"1.2","longName":"caTISSUE CAE","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000562","version":"1","longName":"edu.pitt.cabig.cae.domain.breast","context":"NCIP"}]},{"publicId":"2857187","version":"1","longName":"CAP Cancer Checklists","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812063","version":"1","longName":"edu.upmc.opi.cabig.caties.cap.domain.breast","context":"NCIP"}]}],"AlternateNames":[{"name":"edu.pitt.cabig.cae.domain.breast.NottinghamHistologicGrade.totalScore","type":"UML Qualified Attr","context":"NCIP"},{"name":"NottinghamHistologicGrade:totalScore","type":"UML Class:UML Attr","context":"NCIP"},{"name":"edu.upmc.opi.cabig.caties.cap.domain.breast.NottinghamHistopathologicGrade.totalScore","type":"UML Qualified Attr","context":"NCIP"},{"name":"NottinghamHistopathologicGrade:totalScore","type":"UML Class:UML Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Total Nottingham Score","type":"Preferred Question Text","description":"Total Nottingham Score","url":null,"context":"NCIP"}],"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE553C-EA3C-5A36-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"REEVESD","dateModified":"2009-07-16","changeDescription":"Permission to Release CDE granted by primary curator, Linda Schmandt, in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}